about
Hepatocellular carcinoma detection by gallium scan and subsequent treatment by gallium maltolate: rationale and case studyIn vitro susceptibility of equine-obtained isolates of Corynebacterium pseudotuberculosis to gallium maltolate and 20 other antimicrobial agents.Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections.Pharmacokinetics of an orally administered methylcellulose formulation of gallium maltolate in neonatal foals.Serum and tissue concentrations of gallium after oral administration of gallium nitrate and gallium maltolate to neonatal calves.Gallium maltolate as an alternative to macrolides for treatment of presumed Rhodococcus equi pneumonia in foals.In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi.Gallium maltolate: safety in neonatal foals following multiple enteral administrations.Evaluation of the efficacy of gallium maltolate for chemoprophylaxis against pneumonia caused by Rhodococcus equi infection in foals.Evaluation of the effect of gallium maltolate on fecal Salmonella shedding in cattle.Pharmacokinetics of gallium maltolate in Lawsonia intracellularis-infected and uninfected rabbits.Comparison of the antimicrobial activities of gallium nitrate and gallium maltolate against Mycobacterium avium subsp. paratuberculosis in vitro.Efficacy of gallium maltolate against Lawsonia intracellularis infection in a rabbit modelAntimicrobial Activity of Gallium Compounds on ESKAPE PathogensTopical treatment with gallium maltolate reduces Treponema pallidum subsp. pertenue burden in primary experimental lesions in a rabbit model of yawsBactericidal activity of 3D-printed hydrogel dressing loaded with gallium maltolateAntimicrobial activity of gallium maltolate against Staphylococcus aureus and methicillin-resistant S. aureus and Staphylococcus pseudintermedius: An in vitro study
P50
Q28237090-AF2B62E3-A50D-46BA-B83F-2DEDAE2106FEQ33899894-83C0193F-456A-4A85-8A9C-D45C4DDDB128Q35336154-3A1F6F64-0E53-4280-A758-2B7BBD53AC46Q39855030-F0698799-E650-4377-8D48-27494894D176Q39878282-84F2124F-2A3C-4ED7-8A98-CB52BBE16089Q41338773-2D70BB2E-8F28-4E38-A3EA-9C72586A11D9Q43017359-A823F549-1144-487C-8FAE-ACFD1DE00764Q43073472-599C4A7E-4BF4-46A6-B86D-4F14FB637A3CQ43454838-024D8BB0-6C73-452F-973D-093317C7EE9DQ43623359-98B9849B-432D-44B0-819C-1FB2617F579DQ45091692-EF1166ED-75B2-4916-B20A-FD1662F0935CQ53263247-CC4EBA1D-1989-4DC6-8B23-C08CBA35B33CQ57108708-50EAE0E1-5DE9-4A13-A06C-D9A98717EAAEQ57158916-165D2CAF-D5C6-4DD1-9AD5-1DEB69223FFBQ61451741-1E45BA53-6D59-4358-910B-3FAB4146B7C7Q64080741-C4740ADE-7E0E-45E1-AEB6-90A735621E15Q85026083-880AE1CB-2803-4888-8045-E510245360F0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Lawrence R Bernstein
@nl
Lawrence R Bernstein
@sl
Lawrence R. Bernstein
@en
Lawrence R. Bernstein
@es
type
label
Lawrence R Bernstein
@nl
Lawrence R Bernstein
@sl
Lawrence R. Bernstein
@en
Lawrence R. Bernstein
@es
prefLabel
Lawrence R Bernstein
@nl
Lawrence R Bernstein
@sl
Lawrence R. Bernstein
@en
Lawrence R. Bernstein
@es
P106
P1153
36051745200
P31
P496
0000-0003-1783-5410